ID: ALA3143595

Max Phase: Preclinical

Molecular Formula: C11H16N5O6P

Molecular Weight: 345.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1[C@H](O)[C@@H](COP(=O)(O)O)O[C@H]1n1cnc2c(N)ncnc21

Standard InChI:  InChI=1S/C11H16N5O6P/c1-5-8(17)6(2-21-23(18,19)20)22-11(5)16-4-15-7-9(12)13-3-14-10(7)16/h3-6,8,11,17H,2H2,1H3,(H2,12,13,14)(H2,18,19,20)/t5-,6-,8+,11-/m1/s1

Standard InChI Key:  BXOQDWIRRJHEGA-JJCHFMHPSA-N

Associated Targets(non-human)

Adenylate kinase 2 147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenylate kinase 3 alpha like 1 137 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenylate kinase 1 103 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 345.25Molecular Weight (Monoisotopic): 345.0838AlogP: -0.59#Rotatable Bonds: 4
Polar Surface Area: 165.84Molecular Species: ACIDHBA: 9HBD: 4
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.23CX Basic pKa: 3.94CX LogP: -3.48CX LogD: -4.47
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: 1.11

References

1. Hai TT, Picker D, Abo M, Hampton A..  (1982)  Species- or isozyme-specific enzyme inhibitors. 7. Selective effects in inhibitions of rat adenylate kinase isozymes by adenosine 5'-phosphate derivatives.,  25  (7): [PMID:6286970] [10.1021/jm00349a008]

Source